Article
Development, Validation, and Clinical Application of an HPLC-Based Method for Determining Adenosine Deaminase Activity in Adenosine Deaminase Deficiency-Severe Combined Immunodeficiency.
The journal of applied laboratory medicine - 1 Jul 2026
Petrik Maria, Litvin Evgeny, Osipyants Andrey, Filkova Aleksandra, Rodina Yulia, Blinov Dmitrii, Grachev Nikolay, Shcherbina Anna
Abstract excerpt
BACKGROUND: Adenosine deaminase (ADA) deficiency is a rare genetic condition leading to severe combined immunodeficiency. Timely and accurate quantification of ADA activity is crucial for both diagnosis and treatment monitoring. This study describes the development and analytical validation of a high-performance liquid chromatography (HPLC)-based method for measuring ADA activity in dried blood spot (DBS)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
